Soldani et al. showed that the metabolic axis between riboflavin and KDM1A may be involved in regulating the morphology of tumor-associated macrophages in patients with colorectal liver metastases, particularly in the inflammatory microenvironment, suggesting that KDM1A may be involved in TME regulation in CRC patients [102]. This evidence concerns the gene KDM1A and neoplasm.